Fig 1: Effects of WYD on enteral transit rate and serological parameters in mice with LIA. (A) Enteral transit ratio; (B) MTL; (C) Gas; (D) SP; (E) AChE; and (F) VIP in mice with LIA by ELISA. Contradistinguished with the No group, #, P<0.05, ##, P<0.01; compared with the Lop + Saline group, *, P<0.05, **, P<0.01. Mice were grouped as follows: No: NC group; Lop + Saline: Lop and saline were used to cure the mice; Lop + WYD-L: Lop and WYD at 10.2 g/kg BW were used to cure the mice; Lop + WYD-M: Lop and WYD at 20.4 g/kg BW were used to cure the mice; Lop + WYD-H: Lop and WYD at 40.8 g/kg BW were used to cure the mice; Lop + Pur: Lop and prucalopride at 0.26 mg/kg BW were used to cure the mice. Lop, loperamide; WYD, Wenyang Yiqi Decoction; Pru, prucalopride; LIA, loperamide-induced astriction; MTL, motilin; Gas, gastrin; SP, substance P; AChE, acetylcholinesterase; VIP, vasoactive intestinal peptide; ELISA, enzyme-linked immunosorbent assay; BW, body weight.
Fig 2: Effect of CCACPs on inflammatory factors in serum, skin and AChE, SOD in brain and ALT and AST in liver of mice irradiated by D-gal injection combined with UVB.(A) Serum levels of IL-6 in mice. (B) Levels of IL-6 in mice skin. (C) Levels of AChE in mice brain. (D) Levels of SOD in mice brain. (E) Levels of ALT in mice liver. (F) Levels of AST in mice liver. (*p < 0.05, **p < 0.01, ***p < 0.001, in relation to D-gal injection combined with UVB irradiation controls; ##p < 0.01, ###p < 0.001, in relation to control group).
Supplier Page from CUSABIO Technology LLC for Mouse Acetylcholinesterase(AChE)ELISA Kit